TORONTO, ON, September 29, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt:  KL1) (formerly Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, announces the grant of 3,505,593 stock options to directors, officers, employees and consultants on September 28, 2022. Of the stock options being issued, 2,074,025 options are being granted to directors and senior officers, 1,131,568 options to employees and 300,000 options to consultants.  Each option allows the holder to acquire one common share in the Company for $0.05 per share.  The stock options are valid for a 5-year period from the date of grant, were issued in accordance with the Company’s Stock Option Plan and are subject to approval by regulatory authorities.

The Company’s Stock Option Plan allows for the issuance of up to 10% of issued and outstanding share capital in the form of incentive stock options. As a result of this grant, the Company has 8,672,259 stock options issued, representing 9.3% of the issued and outstanding share capital.

For further information, please contact:

Robin Cook
Corporate Development
(416) 809-1738
[email protected]